Viewing Study NCT06148402

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2026-05-26 @ 5:52 PM
Study NCT ID: NCT06148402
Status: RECRUITING
Last Update Posted: 2024-05-13
First Post: 2023-11-03
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With Unresectable/Metastatic Colorectal Cancer
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unresectable/Metastatic Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Fruquintinib View
None Camrelizumab View
None Capecitabine View
None mCRC View
None salvage therapy View